The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma - A Randomized, Double-blind, Placebo-controlled Trial of HDM-AIT

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

26 Jan 2023 Results assessing effect of house dust mite-sublingual allergen immunotherapy (HDM-SLIT) on the bronchial epithelial antiviral and inflammatory responses in patients with allergic asthma published in the American Journal of Respiratory and Critical Care Medicine
21 Apr 2022 Status changed from active, no longer recruiting to completed.
02 Aug 2021 Planned End Date changed from 15 Jun 2022 to 30 Jul 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com